109 related articles for article (PubMed ID: 18353306)
1. Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant.
Hamann M; Sander SE; Richter A
Eur J Pharmacol; 2008 May; 586(1-3):156-9. PubMed ID: 18353306
[TBL] [Abstract][Full Text] [Related]
2. The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia.
Richter A; Hamann M
Eur J Pharmacol; 2003 Sep; 478(1):47-52. PubMed ID: 14555184
[TBL] [Abstract][Full Text] [Related]
3. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster.
Richter A; Hamann M
Eur J Pharmacol; 2004 Oct; 502(1-2):105-8. PubMed ID: 15464095
[TBL] [Abstract][Full Text] [Related]
4. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
5. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
6. Extracellular amino acid levels in the striatum of the dt(sz) mutant, a model of paroxysmal dystonia.
Hamann M; Sohr R; Morgenstern R; Richter A
Neuroscience; 2008 Nov; 157(1):188-95. PubMed ID: 18824218
[TBL] [Abstract][Full Text] [Related]
7. Effects of rubral microinjections of muscimol and bicuculline in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Brain Res; 2004 May; 1008(1):126-30. PubMed ID: 15081391
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of neurosteroids in a rodent model of primary paroxysmal dystonia.
Hamann M; Richter F; Richter A
Horm Behav; 2007 Aug; 52(2):220-7. PubMed ID: 17553499
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dt(sz) mutant hamster.
Hamann M; Richter A; Meillasson FV; Nitsch C; Ebert U
Brain Res; 2007 May; 1150():190-9. PubMed ID: 17391652
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in striatal nitric oxide synthase-immunoreactive interneurones in the dystonic dtsz mutant hamster.
Sander SE; Hamann M; Richter A
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):74-82. PubMed ID: 16409555
[TBL] [Abstract][Full Text] [Related]
11. Persistent changes of corticostriatal plasticity in dt(sz) mutant hamsters after age-dependent remission of dystonia.
Avchalumov Y; Volkmann CE; Rückborn K; Hamann M; Kirschstein T; Richter A; Köhling R
Neuroscience; 2013 Oct; 250():60-9. PubMed ID: 23827309
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and autoradiographic studies on the pathophysiological role of GABA(B) receptors in the dystonic hamster: pronounced antidystonic effects of baclofen after striatal injections.
Sander SE; Richter F; Raymond R; Diwan M; Lange N; Nobrega JN; Richter A
Neuroscience; 2009 Aug; 162(2):423-30. PubMed ID: 19427369
[TBL] [Abstract][Full Text] [Related]
13. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
Richter A; Löschmann PA; Löscher W
Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
Röver S; Cesura AM; Huguenin P; Kettler R; Szente A
J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907
[TBL] [Abstract][Full Text] [Related]
15. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia.
Hamann M; Richter A
Neurobiol Dis; 2004 Jun; 16(1):78-84. PubMed ID: 15207264
[TBL] [Abstract][Full Text] [Related]
16. Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Grégoire L; Rassoulpour A; Guidetti P; Samadi P; Bédard PJ; Izzo E; Schwarcz R; Di Paolo T
Behav Brain Res; 2008 Jan; 186(2):161-7. PubMed ID: 17868931
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia.
Hamann M; Raymond R; Varughesi S; Nobrega JN; Richter A
Brain Res; 2006 Jul; 1099(1):176-82. PubMed ID: 16764832
[TBL] [Abstract][Full Text] [Related]
18. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
19. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
Sander SE; Richter A
Eur J Pharmacol; 2007 Jun; 563(1-3):102-8. PubMed ID: 17349621
[TBL] [Abstract][Full Text] [Related]
20. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Eur J Pharmacol; 2002 May; 443(1-3):59-70. PubMed ID: 12044793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
